Google Alert - hepatitis c

[Guest guest]

News

10 new results for hepatitis c

Santaris Pharma A/S to Report New Clinical Data From Miravirsen Phase 2a Study ...MarketWatch (press release)Developed using Santaris Pharma A/S proprietary Locked Nucleic Acid (LNA) Drug Platform, miravirsen is an inhibitor of miR-122, a liver specific microRNA that the Hepatitis C virus requires for replication.

Miravirsen is designed to recognize and ...See all stories on this topic »

Devon Nicholson files suit against WWECANOEThe wrestler, who has Hepatitis C, is seeking almost $6 million from WWE. The suit, filed August 26th and served September 26, 2011 in the Ontario Superior Court of Justice, is based on the fact that WWE offered Nicholson a standard contract on June 5, ...See all stories on this topic »

CANOE

Evaluation of endothelial function and subclinical atherosclerosis in ...7thSpace Interactive (press release)Relationship of hepatitis C virus (HCV) infection with an increased risk of cardiovascular disease (CVD) in HIV-infected patients remains controversial. We evaluated endothelial function and subclinical atherosclerosis in

HIV-infected patients with and ...See all stories on this topic »

Obesity May Explain Liver Cancer Hike Among LatinosThe Oncology ReportAlthough liver cancer, or hepatocellular carcinoma (HCC), is most common in Asia and Africa, the incidence is on the rise in the United States, primarily due to hepatitis C virus infection. There are 20000 new HCC cases in this country each year, ...See all stories on this topic »

Virus has Las Vegas police detective preaching precautionLas Vegas Review - JournalIn 2008 Nogle learned he had hepatitis C, a potentially deadly virus that attacks the liver. The virus is primarily passed from person to person through direct blood-to-blood contact, including mucous membranes or broken skin. ...See all stories on this topic »

OPINION: When the private health sector falls shortBusiness DayIt passed fairly unnoticed in SA, a country where hepatitis B virus infection is endemic. Chronic hepatitis B infection accounts for about half of all cases of liver cancer in SA. Hepatitis C has a far lower prevalence but can cause chronic liver ...See all stories on this topic »

With 9 Months Down, These Are the Best Stocks of 2011DailyFinancePharmasset is a clinical-stage pharma company with a focus on treating the hepatitis C virus via oral therapeutics. Since the beginning of the year, the company has received fast-track status from the FDA for one of its hepatitis C drugs, entered into ...See all stories on this topic »

New Data from Boehringer Ingelheim HCV Portfolio to be Presented at AASLDMarketWatch (press release)RIDGEFIELD, Conn., Oct. 3, 2011 /PRNewswire via COMTEX/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that new data from its hepatitis C virus (HCV) portfolio will be presented in scientific sessions at The Liver Meeting® 2011, ...See all stories on this topic »

Beacon NewsFlashes – October 3, 2011The AIDS BeaconClinical Trial To Test Victrelis In People With HIV And Hepatitis C Is Currently Recruiting Participants – A Phase 4 clinical trial that will test the efficacy of Victrelis (boceprevir) in HIV-positive adults with hepatitis C virus compared to ...See all stories on this topic »

Bristol-Myers Squibb to present at The Liver MeetingDrug Store NewsKey presentations set to take place at the meeting, called The Liver Meeting, include studies on the hepatitis B drug Baraclude (entecavir) and drugs under development for hepatitis C and liver cancer. "Bristol-Myers Squibb is at the forefront of ...See all stories on this topic »